Optimal management of neutropenic fever in patients with cancer

Andrea J. Zimmer, Alison G. Freifeld

Research output: Contribution to journalReview articlepeer-review

17 Scopus citations


Febrile neutropenia remains an important complication of treatment with cytotoxic chemotherapy. It is often the first and sometimes the only sign or symptom of infection in this vulnerable patient population. Urgent and appropriate evaluation and treatment are imperative because delay in initiating appropriate antibiotic therapy may be life threatening. Selection of antibiotics should be based on the patient’s symptoms, previous culture data, and institutional antibiograms. Ongoing therapy should be guided by culture and clinical data. Antimicrobial resistance is of great concern, particularly in this population, so careful attention to antibiotic selection and duration is needed.

Original languageEnglish (US)
Pages (from-to)19-24
Number of pages6
JournalJournal of oncology practice
Issue number1
StatePublished - Jan 1 2019

ASJC Scopus subject areas

  • Oncology
  • Oncology(nursing)
  • Health Policy


Dive into the research topics of 'Optimal management of neutropenic fever in patients with cancer'. Together they form a unique fingerprint.

Cite this